Tuesday, 4 February 2025

On oral fecal microbiota transplantation


 

Could fecal microbiota transplantation help patients heal after stem cell transplantation?


A new study published in Nature Communications shows that oral fecal microbiota transplantation (FMT) is a safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood cancers. This research is part of a phase 2 clinical trial led by Armin Rashidi, MD, PhD, a medical oncologist at Fred Hutch. 

The randomized phase of the trial will study whether FMT improves health outcomes for patients undergoing stem cell transplantation, such as less acute graft-versus-host disease, fewer hospitalizations, fewer infections, better quality of life and longer survival. 

 Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

No comments:

Post a Comment

Pharmaceutical Microbiology Resources

Special offers